SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about outcome of board meeting

28 Oct 2021 Evaluate
Hester Biosciences has informed that Board of Directors, in its Meeting held today, have approved the followings: Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30 September 2021, as recommended by Audit Committee; Appointment of Priya Gandhi as a Whole-time Director of the Company for the period for 5 (Five) years, subject to approval of members; Appointment of Ameet Desai as an Independent Director of the Company for the period of 5 (Five) years, subject to approval of members. Also attached the approved standalone and consolidated unaudited financial results and limited review reports; and Press Release issued in this regard.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×